Vandral Retard 75 mg hard capsulesof prolonged release
Vandral Retard 150 mg hard capsulesof prolonged release
Vandral Retard 225 mg hard capsulesof prolonged release
venlafaxine
Vandral Retard contains the active ingredient venlafaxine.
Vandral Retard is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. The exact way in which antidepressants work is not fully understood, but they may help increase the levels of serotonin and norepinephrine in the brain.
Vandral Retard is a treatment for adults with depression. It is also a treatment for adults with the following anxiety disorders: generalized anxiety disorder, social anxiety disorder (fear or avoidance of social situations), panic disorder (panic attacks). Treating depressive and anxiety disorders properly is important to help you feel better. If left untreated, your condition may not go away or may worsen and become harder to treat.
Consult your doctor or pharmacistbeforestarting to take Vandral Retard:
Vandral Retard may cause restlessness or difficulty sitting or staying still during the first few weeks of treatment. You should consult your doctor if this occurs.
Do not drink alcohol during treatment with Vandral Retard, as it may cause extreme fatigue and loss of consciousness. Taking Vandral Retard with certain medications and/or alcohol may worsen symptoms of depression and other conditions, such as anxiety disorders.
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming yourself or committing suicide. These thoughtsmay increase when starting to take antidepressants, as all these medications take time to work, usually two weeks, although sometimes more. These thoughts may also occur when your dose is reduced or during the interruption of treatment with Vandral Retard.
This is more likely to happen:
If you have thoughts of harming yourself or committing suicide at any time, contact your doctor or go to the hospital directly.
You may find it helpful to tell a close family member or friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Dry mouth
Dry mouth has been reported in 10% of patients treated with venlafaxine. This may increase the risk of tooth decay (caries). Therefore, you should take good care of your dental hygiene.
Diabetes
Sexual problems
Some medications in the group to which Vandral Retard belongs (called ISRN) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Vandral Retard should not be used normally in the treatment of children and adolescents under 18 years of age. Additionally, you should know that in patients under 18 years of age, there is a higher risk of adverse effects such as suicidal behavior, suicidal thoughts, and hostility (predominantly aggression, confrontational behavior, and irritability) when taking this type of medication. Despite this, your doctor may prescribe this medication to patients under 18 years of age when they decide it is in the best interest of the patient. If your doctor has prescribed this medication to a patient under 18 years of age, and you wish to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen in these patients under 18 years of age who are taking Vandral Retard.
Furthermore, the long-term safety in relation to growth, maturation, and cognitive and behavioral development has not been demonstrated.
Taking Vandral Retard with other medications
Inform your doctor or pharmacist if you are using or have used recently or may need to use any other medication.
Your doctor should decide if you can take Vandral Retard with other medications.
Do not start or stop taking any medication, including those sold without a prescription, natural remedies, and herbal products, before checking with your doctor or pharmacist.
A potentially life-threatening condition, or reactions similar to Neuroleptic Malignant Syndrome (NMS) (see the section "Possible Side Effects") may occur with treatment with venlafaxine, particularly when taken with other medications.
Examples of these medications include:
The signs and symptoms of serotonin syndrome may include a combination of the following:
restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhea, coma, nausea, vomiting.
In its most severe form, serotonin syndrome may resemble neuroleptic malignant syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle rigidity, confusion, increased muscle enzymes (determined by blood test).
Inform your doctor immediately or go to the nearest hospital emergency room if you think you are experiencing serotonin syndrome.
Inform your doctor if you are taking medications that may affect your heart rhythm.
Some examples of these medications include:
The following medications may interact with Vandral Retard and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medications that contain:
Vandral Retard should be taken with food (see section 3 "How to take Vandral Retard").
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication. You should only take Vandral Retard after discussing the possible benefits and risks for the unborn child with your doctor.
Make sure your midwife and/or doctor know that you are taking Vandral Retard. When taken during pregnancy, similar medications (ISRS) may increase the risk of a severe condition in newborns, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and turn blue. These symptoms usually start within the first 24 hours after the baby's birth. If this happens to your baby, you should contact your midwife and/or doctor immediately.
If you take Vandral Retard in the final stages of pregnancy, there may be a higher risk of excessive vaginal bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking Vandral Retard so they can advise you.
If you are taking this medication during the final stages of pregnancy, in addition to breathing problems, another symptom that your baby may have when born is feeding problems. If your baby has these symptoms when born and you are concerned, contact your doctor and/or midwife who can advise you.
Vandral Retard passes into breast milk. There is a risk of an effect on the baby. Therefore, you should discuss the case with your doctor, and they will decide if you should stop breastfeeding or stop taking this medication.
Do not drive or operate tools or machines until you know how this medication affects you.
Follow exactly the administration instructions of this medication as indicated by your doctor.This medication.In case of doubt, consult your doctor or pharmacist again.
The usual initial dose recommended for the treatment of depression, generalized anxiety disorder and social anxiety disorder is 75 mg per day. Your doctor may increase the dose gradually and if necessary, even more up to a maximum of 375 mg per day for depression. If you are being treated for panic disorder, your doctor will start with a lower dose (37.5 mg) and then increase the dose gradually. The maximum dose for generalized anxiety disorder, social anxiety disorder and panic disorder is 225 mg/day.
Take Vandral Retard approximately at the same time every day, either in the morning or at night. The capsules must be swallowed whole with liquid and should not be opened, crushed, chewed or dissolved.
Vandral Retard should be taken with food.
If you have liver or kidney problems, talk to your doctor as your dose of this medication may need to be different.
Do not stop taking this medication without consulting your doctor (see section “If you interrupt treatment with Vandral Retard”).
In case of overdose or accidental ingestion, contact your doctor, pharmacist or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount ingested.
Overdose can put your life in danger, especially with the simultaneous taking of certain medications and/or alcohol (see Taking Vandral Retard with other medications).
The symptoms of a possible overdose may include palpitations, changes in alertness (ranging from drowsiness to coma) blurred vision, convulsions or seizures and vomiting.
If you have not taken a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only one dose as usual. Do not take a double dose to compensate for the missed doses. Do not take more than the daily dose of Vandral Retard that you have been prescribed in a day.
Do not stop taking your treatment or reduce the dose without consulting your doctor, even if you feel better. If your doctor thinks you no longer need Vandral Retard, they may ask you to reduce the dose gradually before interrupting treatment completely. It is known that adverse effects occur when people stop using this medication, especially when it is stopped suddenly or if the dose is reduced very quickly. Some patients may experience symptoms such as suicidal thoughts, aggression, fatigue, dizziness, instability, headaches, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling or, in rare cases, electric shock sensations, weakness, sweating, convulsions or symptoms similar to the flu, vision problems and increased blood pressure (which can cause headaches, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you on how to gradually interrupt treatment with Vandral Retard. This may take several weeks or months. In some patients, the interruption may need to be done very gradually over months or more. If you experience any of these or other symptoms that bother you, consult your doctor for advice.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If any of the following side effects occur, do not take more Vandral Retard.Inform your doctor immediately, or go to the nearest hospital emergency department:
Rare (may affect up to 1 in 100 people)
Uncommon (may affect up to 1 in 1,000 people)
In its most severe form, serotonin syndrome may resemble neuroleptic malignant syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle rigidity, confusion, increased muscle enzymes (determined by blood tests).
Unknown frequency (cannot be estimated from available data)
Other side effects that you should inform your doctor are (the frequency of these side effects are included in the list below "other side effects that may occur"):
Do not worry if you see white pellets or small granules in your stool after taking this medicine. Inside the Vandral Retard capsules, there are spheroids (small white pellets) that contain the active ingredient (venlafaxine). These spheroids are released from the capsule in the stomach. As they circulate through the stomach and intestines, venlafaxine is released slowly. The "shell" of the spheroid does not dissolve and is eliminated in the stool. Therefore, although you see spheroids in the stool, the dose of the medicine has been absorbed.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Uncommon (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Unknown frequency (cannot be estimated from available data)
Vandral Retard may sometimes cause unwanted effects that you may not be aware of, such as increased blood pressure or abnormal heartbeat; mild changes in liver enzyme levels, sodium, or cholesterol. Less frequently, Vandral Retard may reduce the function of platelets in the blood, leading to an increased risk of petechiae or bleeding. Therefore, your doctor may wish to perform occasional blood tests, particularly if you have been taking Vandral Retard for a long time.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Do not store at temperatures above30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment..
The active ingredient is venlafaxine.
Each prolonged-release capsule contains 84.85 mg of venlafaxine hydrochloride, equivalent to 75 mg of venlafaxine base.
The other components are:
Capule content:microcrystalline cellulose, ethylcellulose, hypromellose, talc.
Capule coating:gelatin, iron oxide red and yellow (E172), titanium dioxide (E171).
Capule printing ink:shellac, iron oxide red (E172), ammonium hydroxide, simethicone, propylene glycol.
Each prolonged-release capsule contains 169.7 mg of venlafaxine hydrochloride, equivalent to 150 mg of venlafaxine base.
The other components are:
Capule content:microcrystalline cellulose, ethylcellulose, hypromellose, talc.
Capule coating:gelatin, iron oxide red and yellow (E172), titanium dioxide (E171).
Capule printing ink:shellac, sodium hydroxide (see section 2), povidone, titanium dioxide (E171), propylene glycol.
Each prolonged-release capsule contains 254.52 mg of venlafaxine hydrochloride, equivalent to 225 mg of venlafaxine base.
The other components are:
Capule content:microcrystalline cellulose, ethylcellulose, hypromellose, talc.
Capule coating:gelatin, iron oxide black, red and yellow (E172), titanium dioxide (E171).
Capule printing ink:shellac, sodium hydroxide (see section 2), povidone, titanium dioxide (E171), propylene glycol.
Vandral Retard 75 mg is a hard (gelatin) prolonged-release capsule, opaque and orange-colored, 19.4 mm x 6.91 mm, with a 'W' and the dose '75' printed in red.
Vandral Retard 75 mg is available in:
Blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100 hard capsules and clinical packs of 500 (10x50) and 1,000 (10x100) hard capsules or in HDPE plastic bottles of 14, 20, 50, 100 hard capsules and clinical packs of 500 and 1,000 hard capsules.
Unit-dose blister packs of 14, 28, 84 and 100 hard capsules.
Vandral Retard 150 mg is a hard (gelatin) prolonged-release capsule, opaque and orange-colored, 23.5 mm x 7.65 mm, with a 'W' and the dose '150' printed in white.
Vandral Retard 150 mg is available in:
Blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100 hard capsules and clinical packs of 500 (10x50) and 1,000 (10x100) hard capsules or in HDPE plastic bottles of 14, 20, 50, 100 hard capsules and clinical packs of 500 and 1,000 hard capsules.
Unit-dose blister packs of 14, 28, 84 and 100 hard capsules.
Vandral Retard 225 mg is an opaque capsule with a light gray-colored coating and a dark orange-colored body, with 'W' and '225' printed in white.
Vandral Retard 225 mg is available in:
Blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100 and clinical packs of 500 (10x50) and 1,000 (10x100).
Unit-dose blister packs of 14, 28, 84 and 100 hard capsules.
Only some package sizes may be marketed.
Marketing authorization holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
or
Pfizer Ireland Pharmaceuticals
Little Connell
Newbridge
County Kildare
Ireland
Viatris Pharmaceuticals, S.L.U.
Calle General Aranaz, 86
28027 Madrid
Spain
Austria | Efectin ER 37.5mg Kapseln Efectin ER 75mg Kapseln Efectin ER 150mg Kapseln |
Bélgica, Luxemburgo | Efexor-Exel 37,5 Efexor-Exel 75 Efexor-Exel 150 Efexor-Exel 225 |
Bulgaria | Efectin ER 75mg Efectin ER 150mg |
República Checa | Efectin ER 37.5mg Efectin ER 75mg Efectin ER 150mg |
Chipre, Grecia, Estonia, Lituania, Portugal | Efexor XR |
Letonia | Efexor XR Efexor XR 75 Efexor XR 150 |
Dinamarca, Finlandia, Islandia, Noruega, Suecia | Efexor Depot |
Francia | Effexor L.P. |
Alemania | Trevilor retard 37,5mg Trevilor retard 75mg Trevilor retard 150mg |
Irlanda, Malta, Reino Unido(Irlanda del Norte) | Efexor XL |
Paises Bajos | Efexor XR 37,5 Efexor XR 75 Efexor XR 150 |
Italia | Efexor Faxine |
Polonia | Efectin ER 37,5 Efectin ER 75 Efectin ER 150 |
Rumanía | Efectin EP 37.5mg Efectin EP 75mg Efectin EP 150mg |
Eslovenia | Efectin ER 37,5mg trde kapsule s podaljšanim sprošcanjem Efectin ER 75mg trde kapsule s podaljšanim sprošcanjem Efectin ER 150mg trde kapsule s podaljšanim sprošcanjem |
España | Vandral Retard 75mgcápsulas duras de liberación prolongada Vandral Retard 150mgcápsulas duras de liberación prolongada Vandral Retard 225 mg cápsulas duras de liberación prolongada |
*[Please note that not all products and concentrations listed may be marketed].
Last revision date of this leaflet: July 2023
For detailed and updated information about this medicinal product, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.